These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9886346)

  • 1. True spectrum of 14q32 translocations in multiple myeloma.
    Pratt G; Fenton JA; Proffitt JA; Rawstron AC; Davies FE; Child JA; Morgan GJ
    Br J Haematol; 1998 Dec; 103(4):1209-10. PubMed ID: 9886346
    [No Abstract]   [Full Text] [Related]  

  • 2. Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
    Liebisch P; Scheck D; Erné SA; Wellmann A; Wendl C; Janczik S; Kolmus S; Kröber A; Einsele H; Straka C; Goldschmidt H; Benner A; Stilgenbauer S; Döhner H
    Genes Chromosomes Cancer; 2005 Jan; 42(1):78-81. PubMed ID: 15390182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombination.
    Fenton JA; Pratt G; Rothwell DG; Rawstron AC; Morgan GJ
    Genes Chromosomes Cancer; 2004 Feb; 39(2):151-5. PubMed ID: 14695995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-hit myeloma with IGH/MYC and IGH/CCND1 translocations.
    Ji M; Jang S; Lee JH; Seo EJ
    Ann Hematol; 2013 Aug; 92(8):1129-31. PubMed ID: 23307601
    [No Abstract]   [Full Text] [Related]  

  • 5. One translocation for 2 lymphoid neoplasms.
    Aussedat G; Baseggio L
    Blood; 2019 Jan; 133(2):180. PubMed ID: 30630847
    [No Abstract]   [Full Text] [Related]  

  • 6. A central nervous system CD56 positive multiple myeloma patient with a t(11;14) (q11;q32): a case report.
    Gozzetti A; Cerase A; Crupi R; Raspadori D; Defina M; Bocchia M; Lauria F
    Leuk Res; 2011 Nov; 35(11):e206-8. PubMed ID: 21767877
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential nuclear organization of translocation-prone genes in nonmalignant B cells from patients with t(14;16) as compared with t(4;14) or t(11;14) myeloma.
    Martin LD; Harizanova J; Righolt CH; Zhu G; Mai S; Belch AR; Pilarski LM
    Genes Chromosomes Cancer; 2013 Jun; 52(6):523-37. PubMed ID: 23460268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
    Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
    Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciding on the therapy of multiple myeloma using genetic risk stratification.
    Gertz MA
    Leuk Lymphoma; 2011 Feb; 52(2):157-8. PubMed ID: 21261501
    [No Abstract]   [Full Text] [Related]  

  • 10. 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias?
    Avet-Loiseau H; Minvielle S; Mellerin MP; Magrangeas F; Bataille R
    Hematol J; 2000; 1(5):292-4. PubMed ID: 11920205
    [No Abstract]   [Full Text] [Related]  

  • 11. Dutcher bodies in multiple myeloma are highly associated with translocation t(4;14) and IgA isotype.
    Jiang N; Qi C; Chang H
    Br J Haematol; 2015 Dec; 171(5):890-2. PubMed ID: 25907777
    [No Abstract]   [Full Text] [Related]  

  • 12. Mott cells in CD20-positive myeloma.
    Ramasamy K; Ladon D; Salisbury J; Ireland R
    Br J Haematol; 2011 Feb; 152(4):366. PubMed ID: 21265822
    [No Abstract]   [Full Text] [Related]  

  • 13. [Close correlations between CD20 expression, a small mature plasma cell morphology and t(11 ; 14) in multiple myeloma].
    Matsuda I; Mori Y; Nakagawa Y; Sawanobori M; Uemura N; Suzuki K
    Rinsho Ketsueki; 2005 Dec; 46(12):1293-7. PubMed ID: 16447802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicolour spectral karyotyping identifies new translocations and a recurring pathway for chromosome loss in multiple myeloma.
    Sawyer JR; Lukacs JL; Thomas EL; Swanson CM; Goosen LS; Sammartino G; Gilliland JC; Munshi NC; Tricot G; Shaughnessy JD; Barlogie B
    Br J Haematol; 2001 Jan; 112(1):167-74. PubMed ID: 11167798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venetoclax plus bortezomib and dexamethasone in heavily pretreated end-stage myeloma patients without t(11;14): A real-world cohort.
    Jelinek T; Popkova T; Duras J; Mihalyova J; Kascak M; Benkova K; Plonkova H; Cerna L; Koristek Z; Simicek M; Hajek R
    Hematol Oncol; 2020 Aug; 38(3):412-414. PubMed ID: 32323881
    [No Abstract]   [Full Text] [Related]  

  • 16. Variable BCL2/BCL2L1 ratio in multiple myeloma with t(11;14).
    Cleynen A; Samur M; Perrot A; Buisson L; Maheo S; Fulciniti M; Attal M; Munshi N; Avet-Loiseau H; Corre J
    Blood; 2018 Dec; 132(26):2778-2780. PubMed ID: 30429160
    [No Abstract]   [Full Text] [Related]  

  • 17. [Long distance vectorette PCR for detecting translocation of IgH gene in switch regions of patients with multiple myeloma].
    Guo C; Huo J; Jiang H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):460-3. PubMed ID: 15972142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetic abnormalities in multiple myeloma: role in oncogenesis and impact on survival].
    Decaux O; Lodé L; Minvielle S; Avet-Loiseau H
    Rev Med Interne; 2007 Oct; 28(10):677-81. PubMed ID: 17559979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolutionary sequence of cytogenetic aberrations during the oncogenesis of plasma cell disorders. Direct evidence at single cell level.
    Nagy Z; Kajtár B; Jáksó P; Dávid M; Kosztolányi S; Hermesz J; Kereskai L; Pajor L; Alpár D
    Leuk Res; 2011 Aug; 35(8):1114-6. PubMed ID: 21377730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A der(22)t(9;22)(p13;q11) in bone marrow cells of a patient with multiple myeloma: a variant of the t(9;14)(p13;q32) associated with a subset of lymphoplasmacytoid lymphoma.
    Smadja NV; Grange MJ
    Cancer Genet Cytogenet; 1998 May; 103(1):78-80. PubMed ID: 9595053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.